Microcytic Anemia and Cancer: When Small Cells Signal More

·

Share

Microcytic anemia is usually caused by iron deficiency, and in adults the most important question is why the iron ran low. Most of the time the answer is benign, such as heavy menstrual periods, pregnancy, or a low-iron diet. But in men and in women past menopause, new iron deficiency is treated as a possible sign of slow bleeding from the gut until proven otherwise, and colorectal or stomach cancer is one of the causes doctors deliberately rule out.

This article explains how microcytic anemia and its association with cancer fit together, which patients need a cancer work-up, and what that work-up involves.

What Is Microcytic Anemia?

Anemia means a low hemoglobin level. “Microcytic” means the red blood cells are smaller than normal red blood cells. On a complete blood count (CBC), cell size is reported as the mean corpuscular volume (MCV), and microcytosis is generally defined as an MCV below about 80 femtoliters (fL) in adults.

Small cells usually go hand in hand with pale cells (hypochromia), because the underlying problem is that the developing red cell cannot make enough hemoglobin. Hemoglobin needs three ingredients: iron, a heme ring, and globin protein chains. A shortage or defect in any of the three produces smaller red cells.

CBC measure Typical adult reference range What happens in microcytic anemia
Hemoglobin About 13.5–17.5 g/dL (men); 12.0–15.5 g/dL (women) Low
MCV (cell size) About 80–100 fL Below 80 fL
MCH (hemoglobin per cell) About 27–33 pg Low
RDW (variation in cell size) About 11.5–14.5% Often raised in iron deficiency; often normal in thalassemia trait

Reference ranges differ slightly between laboratories, so always compare your results with the range printed on your own report.

The Main Causes of Small Red Cells

Clinicians often use a short list to sort out microcytic anemia, because only a handful of conditions produce it:

  • Iron deficiency anemia — by far the most common cause worldwide, due to blood loss, poor intake, poor absorption, or increased demand (pregnancy, growth).
  • Anemia of chronic disease (anemia of inflammation) — usually normocytic, but it can become mildly microcytic in long-standing inflammation, infection, or cancer.
  • Thalassemia trait — an inherited reduction in globin chain production that causes small cells, often with a near-normal hemoglobin.
  • Sideroblastic anemia — a rare defect in heme production, which can be inherited or acquired (for example from alcohol, lead, or certain medicines).
  • Lead poisoning — interferes with heme synthesis, mainly a concern in children and certain occupations.

Each of these disrupts the way the erythrocyte assembles hemoglobin. Only the first two have a meaningful link with cancer, which is why the laboratory work-up focuses on separating them.

How Cancer Leads to Microcytic Anemia

Cancer can produce small red cells through two different routes, and many patients have a mixture of both.

Route 1: Slow bleeding and iron loss

Tumors of the digestive tract are fragile and bleed in small amounts, often invisibly. Over months this drains the body’s iron stores, and once they are empty the marrow starts producing small, pale cells. Colorectal cancer, especially on the right side of the colon, is the classic example because the blood mixes into the stool and is rarely noticed. Stomach and esophageal cancers can do the same. Less commonly, bleeding from the bladder, kidney, or uterus causes iron loss.

Cancers and surgery can also reduce iron absorption. Iron is absorbed mainly in the duodenum, so disease or operations affecting the stomach and upper small bowel can cut iron uptake.

Route 2: Inflammation locking iron away

Many cancers trigger chronic inflammation. The liver responds by raising hepcidin, the hormone that controls iron release. High hepcidin traps iron inside storage cells and blocks absorption from the gut, so the marrow is starved of iron even when total body stores are adequate. This pattern is anemia of inflammation. It is typically normocytic at first but can drift into the microcytic range over time.

Blood cancers form a separate category. Leukemias, lymphomas, and myeloma usually cause normocytic anemia by crowding the bone marrow, not microcytic anemia. For a wider view of how these conditions interact, see our overview of anemia and cancer.

Who Needs to Be Checked for Cancer?

Microcytic anemia by itself does not mean cancer. The context decides how far the investigation goes. In my practice, the patients who always get a gastrointestinal evaluation are:

  • Men of any adult age with confirmed iron deficiency anemia
  • Postmenopausal women with confirmed iron deficiency anemia
  • Anyone with iron deficiency plus alarm symptoms, regardless of age or sex
  • Patients whose iron deficiency comes back after treatment without an obvious explanation

Alarm symptoms that raise concern include:

  • Unexplained weight loss
  • A change in bowel habit lasting several weeks
  • Blood in or on the stool, or black, tarry stools
  • Difficulty swallowing, persistent indigestion, or early fullness after meals
  • Abdominal pain or a palpable lump
  • A family history of bowel or stomach cancer

In a premenopausal woman with heavy periods and no alarm symptoms, doctors often treat the iron deficiency and watch the response. Guidelines still recommend screening for celiac disease in most adults with iron deficiency, since it is a common and easily missed cause of poor absorption.

Diagnosis and Testing

The work-up has two stages: first confirm what type of microcytic anemia it is, then find the source.

Stage 1: Blood tests

Test Iron deficiency Anemia of inflammation Thalassemia trait
Ferritin Low (under about 30 ng/mL strongly suggests it) Normal or high Normal
Serum iron Low Low Normal
Transferrin / TIBC High Low or normal Normal
Transferrin saturation Low Low or normal Normal
Red cell count Low Low Often normal or high

Ferritin is the single most useful test, but it rises with inflammation. A cancer patient can have both iron deficiency and inflammation, so a “normal” ferritin does not always exclude low iron. Doctors then weigh transferrin saturation and the clinical picture together.

Stage 2: Finding the source

When iron deficiency is confirmed in a higher-risk patient, the standard next step is bidirectional endoscopy: a gastroscopy to inspect the esophagus, stomach, and duodenum, and a colonoscopy to examine the large bowel. If both are clear, a CT scan, capsule endoscopy of the small bowel, or urine testing may follow. A bone marrow examination is rarely needed for microcytic anemia and is reserved for puzzling cases, such as suspected sideroblastic anemia or a coexisting hematologic disorder.

Treatment and Management

Treatment has two goals running in parallel: replace the missing iron and deal with the cause.

  • Oral iron is the first choice for most people. Once-daily or alternate-day dosing is often better tolerated and absorbed than multiple daily doses. Hemoglobin usually starts to rise within a few weeks.
  • Intravenous iron is used when oral iron is not tolerated, not absorbed, or not fast enough, which is common in cancer patients and those with inflammatory conditions.
  • Blood transfusion is reserved for severe or symptomatic anemia, or active bleeding.
  • Treating the cancer, whether by surgery, chemotherapy, or other means, removes the bleeding source and reduces inflammation, which allows iron levels to recover.

One key point: iron tablets can correct the blood count and hide the underlying problem. Starting iron is fine, but it should never replace the search for a cause in someone who needs one.

Key Takeaways

  • Microcytic anemia means small red cells, usually an MCV under about 80 fL, and iron deficiency is the most common cause.
  • Cancer causes microcytic anemia mainly through slow gastrointestinal bleeding and, less often, through inflammation that blocks iron use.
  • Men and postmenopausal women with iron deficiency anemia should be evaluated for a bleeding source in the gut, even without symptoms.
  • Ferritin is the key blood test, but inflammation can falsely raise it.
  • Correcting the anemia with iron is not enough; the cause must be found.

Frequently Asked Questions

Is microcytic anemia a sign of cancer?

It can be, but usually it is not. Most microcytic anemia comes from iron deficiency due to menstruation, pregnancy, diet, or benign bleeding, or from inherited thalassemia trait. Cancer becomes a real concern when iron deficiency appears in men, postmenopausal women, or anyone with alarm symptoms.

Which cancers most often cause microcytic anemia?

Cancers of the digestive tract are the main culprits, particularly colorectal and stomach cancers, because they bleed slowly over time. Right-sided colon cancer is known for causing iron deficiency with few other early symptoms. Blood cancers such as leukemia more often cause normocytic anemia.

Can a normal ferritin rule out iron deficiency in cancer?

Not always. Ferritin is an inflammation marker as well as an iron store marker, so it can read normal or high in someone with cancer who is still iron deficient. Doctors look at transferrin saturation and the overall picture to decide.

Should I take iron supplements while waiting for tests?

Your doctor may start iron before tests are complete, and that is reasonable. Iron can slightly darken stools, so mention it before any stool tests. Do not self-treat long term without finding out why you became iron deficient.

For more on anemia types and their causes, visit our anemia guide.

Written by
Coagulation & Thrombosis, Haematology, Platelet Biology
Contact [email protected] marilenacresce1 mcrescente Queen Mary, University of London April 16, 2020 Profiling the eicosanoid networks that underlie the anti- and pro-thrombotic effects of aspirin I’m a platelet biologist and pharmacologist of thrombosis. I did my PhD between the University of Perugia and the “John Paul II” Research in Campobasso, Italy. After my PhD, I worked in Denisa Wagner’s lab…
View Full Profile →
Web Admin Avatar